Cardio Diagnostics Holdings Inc (CDIO) Stock: A Closer Look

Cardio Diagnostics Holdings Inc [CDIO] stock prices are up 7.10% to $0.33 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The CDIO shares have lost -0.85% over the last week, with a monthly amount drifted -27.66%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

The stock price of Cardio Diagnostics Holdings Inc [CDIO] has been fluctuating between $0.19 and $1.77 over the past year. Cardio Diagnostics Holdings Inc [NASDAQ: CDIO] shares were valued at $0.33 at the most recent close of the market.

Analyzing the CDIO fundamentals

The Cardio Diagnostics Holdings Inc [NASDAQ:CDIO] reported sales of 0.03M for trailing twelve months, representing a drop of -15.03%. Gross Profit Margin for this corporation currently stands at -0.41% with Operating Profit Margin at -239.78%, Pretax Profit Margin comes in at -240.28%, and Net Profit Margin reading is -240.28%. To continue investigating profitability, this company’s Return on Assets is posted at -0.79, Equity is -1.73 and Total Capital is -0.84. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2933 points at the first support level, and at 0.2567 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3533, and for the 2nd resistance point, it is at 0.3767.

Ratios To Look Out For

It’s worth pointing out that Cardio Diagnostics Holdings Inc [NASDAQ:CDIO]’s Current Ratio is 13.92. On the other hand, the Quick Ratio is 13.92, and the Cash Ratio is 12.39. Considering the valuation of this stock, the price to sales ratio is 568.72, the price to book ratio is 1.57.

Transactions by insiders

Recent insider trading involved Philibert Robert, Chief Medical Officer, that happened on Sep 06 ’24 when 34075.0 shares were purchased. Chief Technology Officer, Dogan Meeshanthini completed a deal on Sep 06 ’24 to buy 68965.0 shares. Meanwhile, Chief Executive Officer Dogan Meeshanthini bought 68965.0 shares on Sep 06 ’24.

Related Posts